Thomas Smith Stock Analyst Profile - Leerink Partners Research Coverage - Stocknear

Thomas Smith

Stock Analyst at Leerink Partners

(3.7)
# 2313
Out of 5,506 analysts
104
Total ratings
Success rate
Average return

36 Stocks

Name Action PT Current % Upside Ratings Updated
RAPT RAPT Therapeutics
Upgrades: Outperform
16 37
30.14 22.76% 3 Sep 26, 2025
EQ Equillium
Downgrades: Market Perform
3 1
1.33 -24.81% 4 Mar 28, 2025
QTTB Q32 Bio
Downgrades: Market Perform
68 9
2.07 334.78% 2 Dec 11, 2024
ACRS Aclaris Therapeutics
Upgrades: Outperform
2 7
1.86 276.34% 7 Nov 19, 2024
ALMS Alumis
Initiates Coverage On: Outperform
29
4.02 621.39% 1 Jul 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
39
10.19 282.73% 1 Apr 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
42 65
n/a n/a 2 Apr 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
26
7.29 256.65% 1 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
33
n/a n/a 2 Feb 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
20
83.92 -76.17% 1 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
30 17
n/a n/a 3 May 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
45 56
n/a n/a 1 Mar 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
430 435
800 -45.63% 3 Mar 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
17 18
n/a n/a 7 Mar 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
36
67.78 -46.89% 1 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
9 7
1.49 369.8% 4 Feb 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
14 21
16.9 24.26% 6 Feb 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 45
21.65 107.85% 2 Jan 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
6
9.88 -39.27% 1 Nov 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
16 19
n/a n/a 2 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
30 20
n/a n/a 4 Nov 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
5 6
5.76 4.17% 2 Nov 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
9 5
0.98 410.2% 3 Oct 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
46 77
n/a n/a 1 Oct 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
17
8.43 101.66% 1 Aug 25, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
55 60
n/a n/a 5 Aug 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
68 64
26.41 142.33% 2 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
66 70
19 268.42% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
225 150
n/a n/a 5 Aug 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 29
14.85 95.29% 5 Jul 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
33 26
2.84 815.49% 3 Jun 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
13 12
n/a n/a 4 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
18 12
29.72 -59.62% 2 Apr 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 10
4 150% 4 Apr 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
675 400
3.82 10371.2% 2 Mar 16, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
42 80
15.94 401.88% 2 Dec 8, 2020